Abemaciclib-based therapy versus tucidinostat-based therapy in patients with HR+HER2− metastatic breast cancer after palbociclib progression: insights and challenges from a comparative cohort study in China
@article{TBCR79777, author = {Nino Balanchivadze and Nicholas J. Robert}, title = {Abemaciclib-based therapy versus tucidinostat-based therapy in patients with HR+HER2− metastatic breast cancer after palbociclib progression: insights and challenges from a comparative cohort study in China}, journal = {Translational Breast Cancer Research}, volume = {4}, number = {0}, year = {2023}, keywords = {}, abstract = {}, issn = {2218-6778}, url = {https://tbcr.amegroups.org/article/view/79777} }